Biomarin Pharmaceutical (BMRN) Stock News
$BMRN · NASDAQ · HEALTHCARE · 3 stories in 30 days$53.50
1D −6.86%
BORSA has published 3 stories on Biomarin Pharmaceutical (BMRN) in the past 30 days. BORSA’s news read on BMRN is leaning bearish at 43/100, based on 3 company events over the past 7 days. Biomarin Pharmaceutical last reported quarterly results on Aug 6, 2026, for the quarter ended Jun 30, 2026.
The wire on $BMRN
newest first · updated · direct subject stories onlyBioMarin reports $122.8 million third-quarter loss
BioMarin reports $122.8 million third-quarter loss.
neutral 50 · impact 30BioMarin reports third-quarter loss of 63 cents a share
BioMarin Pharmaceutical reported a third-quarter loss of 63 cents a share. The per-share result is the only figure in hand; revenue, the year-earlier comparison and any guidance are not yet part of the picture. A loss on its own does not show whether the quarter beat or missed expectations.
bearish 35 · impact 40